Literature DB >> 7884915

Mapping the hemagglutination domain of rotaviruses.

E M Fuentes-Pananá1, S López, M Gorziglia, C F Arias.   

Abstract

Most strains of animal rotaviruses are able to agglutinate erythrocytes, and the surface protein VP4 is the virus hemagglutinin. To map the hemagglutination domain on VP4 while preserving the conformation of the protein, we constructed full-length chimeras between the VP4 genes of hemagglutinating (YM) and nonhemagglutinating (KU) rotavirus strains. The parental and chimeric genes were expressed in insect cells, and the recombinant VP4 proteins were evaluated for their capacity to agglutinate human type O erythrocytes. Three chimeric genes, encoding amino acids 1 to 208 (QKU), 93 to 208 (QC), and 93 to 776 (QYM) of the YM VP4 protein in a KU VP4 background, were constructed. YM VP4 and chimeras QKU and QC were shown to specifically hemagglutinate, indicating that the region between amino acids 93 and 208 of YM VP4 is sufficient to determine the hemagglutination activity of the protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884915      PMCID: PMC188943     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites.

Authors:  E R Mackow; M Y Yamanaka; M N Dang; H B Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.

Authors:  K Taniguchi; W L Maloy; K Nishikawa; K Y Green; Y Hoshino; S Urasawa; A Z Kapikian; R M Chanock; M Gorziglia
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

Review 3.  Rotavirus protein structure and function.

Authors:  G W Both; A R Bellamy; D B Mitchell
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

4.  Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation.

Authors:  A R Kalica; J Flores; H B Greenberg
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

5.  Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.

Authors:  M Gorziglia; G Larralde; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant.

Authors:  E R Mackow; J W Barnett; H Chan; H B Greenberg
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  SA11 rotavirus is specifically inhibited by an acetylated sialic acid.

Authors:  R E Willoughby; R H Yolken
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

8.  Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption.

Authors:  K Fukudome; O Yoshie; T Konno
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

9.  The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus.

Authors:  M Lizano; S López; C F Arias
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Characterization of binding of simian rotavirus SA-11 to cultured epithelial cells.

Authors:  D J Keljo; A K Smith
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Mar-Apr       Impact factor: 2.839

View more
  17 in total

1.  Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core.

Authors:  P R Dormitzer; H B Greenberg; S C Harrison
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Gerhard Wagner; Stephen C Harrison
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

3.  Trypsin cleavage stabilizes the rotavirus VP4 spike.

Authors:  S E Crawford; S K Mukherjee; M K Estes; J A Lawton; A L Shaw; R F Ramig; B V Prasad
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells.

Authors:  M J Hewish; Y Takada; B S Coulson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells.

Authors:  B S Coulson; S L Londrigan; D J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  Characterization of neuraminidase-resistant mutants derived from rotavirus porcine strain OSU.

Authors:  José Agustín López; Antonio José Maldonado; Marlene Gerder; José Abanero; Juan Murgich; Flor H Pujol; Ferdinando Liprandi; Juan Ernesto Ludert
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  A neutralizing monoclonal antibody to bovine rotavirus VP8 neutralizes rotavirus infection without inhibiting virus attachment to MA-104 cells.

Authors:  J Lee; L A Babiuk; D Yoo
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

8.  Characterization of the interaction between VP8 of bovine rotavirus C486 and cellular components on MA-104 cells and erythrocytes.

Authors:  J Lee; D Yoo; M J Redmond; S K Attah-Poku; J V van den Hurk; L A Babiuk
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

9.  Interactions between the two surface proteins of rotavirus may alter the receptor-binding specificity of the virus.

Authors:  E Méndez; C F Arias; S López
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  Modeling of the rotavirus group C capsid predicts a surface topology distinct from other rotavirus species.

Authors:  Elif Eren; Kimberly Zamuda; John T Patton
Journal:  Virology       Date:  2015-11-02       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.